Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-Terminal Peptide Immunization
出版年份 2022 全文链接
标题
Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-Terminal Peptide Immunization
作者
关键词
-
出版物
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Volume 41, Issue 2, Pages 87-93
出版商
Mary Ann Liebert Inc
发表日期
2022-04-27
DOI
10.1089/mab.2021.0064
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma
- (2021) Teizo Asano et al. ONCOLOGY REPORTS
- Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow Cytometry
- (2021) Hideki Hosono et al. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
- Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry
- (2021) Ren Nanamiya et al. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
- Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin
- (2021) Tomohiro Tanaka et al. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
- CCR4 as a Therapeutic Target for Cancer Immunotherapy
- (2021) Osamu Yoshie Cancers
- Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
- (2020) Yoshikazu Furusawa et al. Oncology Letters
- Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas
- (2020) Mika Kaneko et al. ONCOLOGY REPORTS
- The anti‑epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab‑16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma
- (2020) Hideki Hosono et al. Oncology Letters
- Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches
- (2020) Torsten Schöneberg et al. PHARMACOLOGICAL REVIEWS
- Targeting Treg cells in cancer immunotherapy
- (2019) Atsushi Tanaka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
- (2019) Toshihiko Doi et al. CLINICAL CANCER RESEARCH
- Sézary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody
- (2018) T. Numata et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
- (2018) Shunsuke Itai et al. Oncotarget
- CCR4-targeted therapy in cutaneous T-cell lymphoma
- (2018) Robert Gniadecki LANCET ONCOLOGY
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
- (2018) Youn H Kim et al. LANCET ONCOLOGY
- Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
- (2015) M. Duvic et al. BLOOD
- Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
- (2015) K. Kurose et al. CLINICAL CANCER RESEARCH
- Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome
- (2014) X. Ni et al. CLINICAL CANCER RESEARCH
- CCR4 and its ligands: from bench to bedside
- (2014) O. Yoshie et al. INTERNATIONAL IMMUNOLOGY
- Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis
- (2014) Yoko Kataoka JOURNAL OF DERMATOLOGY
- Mogamulizumab
- (2012) Joshuan M. Subramaniam et al. DRUGS
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
- (2010) T. Ishii et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now